Form 4: Align Technology Director Kevin Dallas Equity Update

Director Kevin J. Dallas acquired 1,745 shares of Align Technology common stock through the vesting of restricted stock units.

Summary

• Director Kevin J. Dallas acquired 1,745 shares of common stock on May 20, 2026, following the vesting of restricted stock units (RSUs).
• The reporting person now holds a total of 16,168 shares of common stock directly.
• A new grant of 1,836 RSUs was awarded to the director on May 20, 2026, scheduled to vest on May 20, 2027, or the date of the next annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation.

Positives

• Director maintains a significant direct equity stake of 16,168 shares in the company.
• Continued alignment of director interests with shareholders through new RSU grants.

Negatives

• None identified; this is a routine disclosure of equity compensation.

Risks

• None identified; this is a standard regulatory filing regarding director compensation.

Future Outlook

The director received a new grant of 1,836 RSUs which are expected to vest on May 20, 2027, subject to continued service.

Industry Context

StockSavvy.ai notes that routine equity vesting for board members is standard practice in the medical technology sector to ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The equity compensation structure is consistent with standard corporate governance practices for S&P 500 companies.
• Director compensation via RSU grants is typical for companies of Align Technology's market capitalization.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of 1,836 RSUs on May 20, 2027.

Key Dates

Keywords

Align Technology, ALGN, Form 4, Insider Trading, Director Compensation, Restricted Stock Units